A02 Request for Information (RFI) for IMAC.docx

THIS IS A REQUEST FOR INFORMATION (RFI)/SOURCES SOUGHT (SS) NOTIFICIATION TO INCLUDE INDUSTRY FEEDBACK

1. Title: Intermediate Medical Acquisition Course (IMAC) for the Defense Health Agency (DHA) / Operational Medicine (OPMED)

2. Contracting Office: Defense Health Agency Contracting Activity (DHACA), R&D Contracting Division 1 - Branch 4

3. Location: Fort Detrick, Frederick, MD

4. Summary: This RFI/SS is issued solely for information and planning purposes and shall not be construed as a solicitation, restrict the Government as to the ultimate acquisition approach, or serve as an obligation on the part of the USAMRDC. In accordance with FAR 15.201(e), responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. Responders are advised that the United States Government will not pay for any information or administrative costs incurred in response to this RFI. All costs associated with responding to this RFI/SS will be solely at the interested responder’s expense. Not responding to this RFI/SS does not preclude participation in any future Request for Proposal, if any is issued. No evaluation letters and/or results will be issued to Responders responding to this RFI/SS.

The information resulting from this RFI/SS will determine interest and capabilities available in the marketplace; and will assist in developing acquisition strategy.

5. Background/Scope: The Defense Health Agency (DHA) / Operational Medicine (OPMED) requires delivery of six (6) offerings annually of the 40‑hour Intermediate Medical Acquisition Course (IMAC). A medically focused DAU‑aligned/certified acquisition course supporting FDA‑regulated product development IAW the attached PWS. This training equips DHA personnel with medical acquisition fundamentals necessary for medical R&D, lifecycle management, and program execution.

The objective of this requirement is to provide annual IMAC courses that align with DAU PM Level II learning objectives, be medically focused (FDA pathways, medical devices, drugs, vaccines), support integrated product teams (IPTs) and provide medically relevant acquisition scenarios and instruction.

How to Respond:

Please submit a Capability Statement that describes relevant experience, expertise, and capabilities based upon the size and scope of this requirement as outlined in the draft PWS.

Each response should include the following business information and must not be more than ten (10) pages in length:

a) Company name, mailing address, e-mail address, telephone, website address (if available), and the name, telephone number, and e-mail address of a point of contact having the authority and knowledge to clarify responses with Government representatives.

b) Unique Entity ID number, CAGE Code, and company structure (Corporation, LLC, partnership, joint venture, etc.). Companies also must be registered in System for Award Management (SAM, at www.sam.gov) to be considered as potential sources.

c) Any and all Government Contracts/IDIQs (e.g. Federal Supply Schedule, OASIS, etc.)

you currently hold (to include the vehicle and your contract number) that could be used to fulfill this requirement.

d) Describe your organization's specific and relevant experience and expertise to fulfill this requirement. Experience must be of similar size and scope. Please provide examples or provide references of previously completed deliverables related to this requirement. Please confirm required DAU certification for the requested course IAW the attached PWS.

e) Provide information relating to capabilities, novel ideas, and industry best practices.

Industry capabilities need to meet the needs of the Government’s requirements as outlined in the draft PWS. Do not regurgitate the draft PWS tasks, rather, outline company specific capabilities that match the work outlined in the draft PWS in order for the Government to make a fair capabilities determination.

Requested (but not required nor evaluated):

Any industry feedback to the attached PWS is encouraged.

Capability statements will be reviewed/evaluated for (1) Relevant experience based on the size and scope of the outlined requirement; (2) Company specific capabilities that match the work outlined in the draft PWS. The formal closing date for this RFI/SS and for the submission of all responses is NLT 21 January 2026 at 12:00PM ET. All responses shall be submitted electronically using PDF or MS Word formats to the POC, Mr. Kevin Jandovitz at kevin.t.jandovitz.civ@health.mil. The Government will not entertain questions regarding this RFI/SS. All responses received will be considered; however, a determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.

Attachment:

· Draft Performance Work Statement (PWS)